https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Intellia_Therapeutics%2C_Inc.Intellia Therapeutics, Inc. - Revizia istoricului2026-05-07T21:04:10ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Intellia_Therapeutics,_Inc.&diff=432991&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Intellia Therapeutics, Inc. listata cu simbolul US.NTLA ==Descriere companie== Intellia Therapeutics, Inc. (http://www.intelliatx.com/) is a clinical-stage genome editing company, which is focused on developing potentially curative therapeutics using Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated 9 (Cas9) technology. The Company's CRISPR/Cas9 is a technology for genome editing, process of altering selected sequ...2024-09-18T18:17:00Z<p>Pagină nouă: Pagina dedicata companiei Intellia Therapeutics, Inc. listata cu simbolul US.NTLA ==Descriere companie== Intellia Therapeutics, Inc. (http://www.intelliatx.com/) is a clinical-stage genome editing company, which is focused on developing potentially curative therapeutics using Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated 9 (Cas9) technology. The Company's CRISPR/Cas9 is a technology for genome editing, process of altering selected sequ...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Intellia Therapeutics, Inc. listata cu simbolul US.NTLA<br />
<br />
==Descriere companie==<br />
Intellia Therapeutics, Inc. (http://www.intelliatx.com/) is a clinical-stage genome editing company, which is focused on developing potentially curative therapeutics using Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated 9 (Cas9) technology. The Company's CRISPR/Cas9 is a technology for genome editing, process of altering selected sequences of genomic deoxyribonucleic acid (DNA). To fully realize the transformative potential of CRISPR/Cas9, the Company uses two primary approaches. The Company’s in vivo programs use intravenously administered CRISPR as the therapy, in which its delivery technology enables precise editing of disease-causing genes directly within specific target tissues. The Company’s ex vivo programs use CRISPR to create the therapy by using engineered human cells to treat cancer and autoimmune diseases.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.NTLA" /><br />
<br />
==Ultimele stiri despre Intellia Therapeutics, Inc. (US.NTLA)==<br />
<dynamicpagelist><br />
category=US.NTLA<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.NTLA]][[Categorie:Stiri despre companii]]</div>Admin